Merck sues U.S. government to halt Medicare drug price negotiation

United States News News

Merck sues U.S. government to halt Medicare drug price negotiation
United States Latest News,United States Headlines
  • 📰 NBCNews
  • ⏱ Reading Time:
  • 29 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 86%

Merck says it sued the U.S. government, seeking an injunction of the drug price negotiation program contained in the Inflation Reduction Act.

, which it argues violates the Fifth and First Amendments to the U.S. Constitution.

Merck asserts this violates the part of the Fifth Amendment that requires the government to pay just compensation for private property taken for public use.than any other country. The Biden administration’s drug pricing reform aims to save $25 billion annually by 2031 through price negotiations for Medicare.

After the government released its roadmap for price negotiations in March, industry lobbyists and lawyers told Reuters that drugmakers were likely to file lawsuits arguing that the government is not complying with the U.S. Constitution.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NBCNews /  🏆 10. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Merck sues Biden administration over Medicare drug price negotiationsMerck sues Biden administration over Medicare drug price negotiationsIn a scathing complaint filed in federal district court, Merck excoriated the Medicare price negotiation process as a 'sham' and 'tantamount to extortion.'
Read more »

Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna dataCancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna dataAdding an experimental mRNA-based vaccine from Moderna Inc and Merck & Co reduced the risk that the most deadly skin cancer would spread by 65% over treatment with an immunotherapy alone in a midstage trial, the companies reported on Monday.
Read more »

Moderna and Merck Cancer Vaccine Used With Keytruda Reduces Risk of Deadly Skin Cancer SpreadingModerna and Merck Cancer Vaccine Used With Keytruda Reduces Risk of Deadly Skin Cancer SpreadingMelanoma is responsible for the large majority of skin cancer deaths, according to the American Cancer Society.
Read more »

Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna dataCancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna dataAn experimental mRNA-based vaccine from Moderna and Merck reduced the risk that the most deadly skin cancer would spread, by 65%, compared to immunotherapy treatment alone, the companies reported on Monday.
Read more »

Merck CEO says decoupling from China would be at huge economic costMerck CEO says decoupling from China would be at huge economic costThe CEO of German technology group Merck KGaA said that unravelling trade ties with China would come at great economic costs and that she was banking on dialogue to ease tensions between Beijing and Western powers.
Read more »

Merck sues HHS over drug negotiation, claims program ‘tantamount to extortion’Merck sues HHS over drug negotiation, claims program ‘tantamount to extortion’In its suit, the drug giant claims that Medicare negotiation program is unconstitutional
Read more »



Render Time: 2025-02-24 10:01:00